|
|
Dual targeting of BCL2 and MCL1 rescues myeloma cells resistant to BCL2 and MCL1 inhibitors associated with the formation of BAX/ BAK hetero-complexes
Carolane Seiller
,
Sophie Maiga
,
Cyrille Touzeau
,
Céline Bellanger
,
Charlotte Kervoëlen
,
et al.
Journal articles
inserm-02563554v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
BH3 profiling as a tool to identify acquired resistance to venetoclax in multiple myeloma
Christelle Dousset
,
Sophie Maïga
,
Patricia Gomez-Bougie
,
Joy Le Coq
,
Cyrille Touzeau
,
et al.
Journal articles
inserm-01353369v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Targeting Oxidative Stress With Auranofin or Prima-1Met to Circumvent p53 or Bax/Bak Deficiency in Myeloma Cells
Benoit Tessoulin
,
Géraldine Descamps
,
Christelle Dousset
,
Martine Amiot
,
Catherine Pellat-Deceunynck
Journal articles
inserm-02055153v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Biological rational for sequential targeting of Bruton tyrosine kinase and Bcl-2 to overcome CD40-induced ABT-199 resistance in mantle cell lymphoma
David Chiron
,
Christelle Dousset
,
Carole Brosseau
,
Cyrille Touzeau
,
Sophie Maïga
,
et al.
Journal articles
inserm-02534385v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Decitabine and Melphalan Fail to Reactivate p73 in p53 Deficient Myeloma Cells
Pierre-Samuel Gillardin
,
Géraldine Descamps
,
Sophie Maiga
,
Benoit Tessoulin
,
Hanane Djamai
,
et al.
Journal articles
inserm-01691503v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
BH3-mimetic toolkit guides the respective use of BCL2 and MCL1 BH3-mimetics in myeloma treatment
Patricia Gomez-Bougie
,
Sophie Maïga
,
Benoit Tessoulin
,
Jessie Bourcier
,
Antoine Bonnet
,
et al.
Journal articles
inserm-01900681v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|